- Home
- LIME vs LKFT Comparison
LIME vs LKFT Comparison
Compare LIME & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
Current Price
$26.04
SELL
Current Price
$29.98
Company Overview
Basic Information| Metric | LIME | LKFT |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2026 | 2007 |
Fundamental Metrics
Financial Performance| Metric | LIME | LKFT |
|---|---|---|
| Price | $26.04 | $29.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | ★ $39.43 | $30.21 |
| AVG Volume (30 Days) | ★ 362.9K | 311.4K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 5.47 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.46 | N/A |
| Revenue Next Year | $15.16 | N/A |
| P/E Ratio | $4.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.87 | $25.68 |
| 52 Week High | $44.38 | $32.41 |
Technical Indicators
Market Signals| Indicator | LIME | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 33.07 | 55.14 |
| Support Level | N/A | $26.63 |
| Resistance Level | $27.16 | $30.08 |
| Average True Range (ATR) | 1.70 | 0.75 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 10.13 | 73.91 |
Price Performance
Historical Comparison LIME
LKFT
About LIME Neutron Holdings Inc. Common Stock
Neutron Holdings Inc is a micromobility company that provides rentals of shared electric scooters (e-scooters) and electric bicycles (e-bikes) through its platform (the Rider App) to be used for short distances in various cities and municipalities around the world.
About LKFT Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.